FDAnews Announces: Pharmaceutical Advertising and Promotion Review Program Workshop on Sept. 20-21, 2022 in Philadelphia, PA

The world of pharmaceutical advertising and promotion is filled with talented people, but they still need help. Not with creating better ads and promotions, they already know how to do that, but for making sure their promotional activities aren’t magnets for FDA untitled letters.

Come to Philadelphia in September for two days of full learning. Attendees will arrive back home with a bag of tricks and tips to ensure their marketing efforts stand up to FDA scrutiny.

Also Read: SEOHost.Net Principal: Recent BIPA Lawsuit against Google Shows Privacy is More Critical than Ever

Attendees will be up-to-date with the latest regulatory and enforcement trends. The agenda includes:

• Understanding Preapproval Communications: Don’t get on the FDA’s or SEC’s radar screens before a product is even approved. Learn how to properly disclose information and remain in compliance.
• How to Maximize Disease Awareness Communications: Take away valuable tips and tricks for using disease awareness communications before and after approval.
• Hurray! You’re Approved: Build the most aggressive but compliant campaign from first day of approval to commercial launch.
• Assuring Promotions Meet FDA Off-Label Standards: Successfully navigate traps that can earn drugmakers a warning letter.
• Itching to do More with Social Media? Discover how to get the message out there, without crossing the line.

The workshop binder includes checklists for promotion approvals/effective review, relevant sections of Form 2253 [CFR], PhRMA’s Principles on DTC Advertising and Principles on Interactions with Healthcare Professionals and more.

Workshop Details

Building a World-Class Pharmaceutical Advertising and Promotion Review Program

A Two-Day Interactive Workshop Presented by PhillyCooke Consulting and FDAnews

Sept. 20-21, 2022 • Philadelphia, PA